{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:17:55Z","timestamp":1787807875686,"version":"build-2784847793"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Highly sensitized kidney transplant candidates possess preformed anti-human leukocyte antigen (HLA) antibodies that substantially reduce their likelihood of receiving a compatible deceased-donor organ. Manual virtual crossmatch (VXM) workflows are sequential and labor-intensive, often limiting histocompatibility laboratories to screening only a subset of eligible candidates during time-sensitive donor evaluations and potentially overlooking compatible recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We designed and developed an automated kidney allocation system (KAS) that links the hospital information system with HLA Fusion antibody data to perform candidate scoring and VXM prediction across the entire eligible active waitlist for every deceased donor workup. We conducted a single-center implementation study consisting of a cross-sectional analysis of 219 active kidney transplant candidates and a retrospective comparison of 67 deceased donor match runs processed by the automated KAS and the historical manual VXM workflow. The primary outcome was identification of potentially compatible highly sensitized patient (HSP) events. Analyse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 219 candidates, 98 (44.7%) were highly sensitized (cPRA \u226580%). Elevated prevalence of HSP was associated with prior transplantation, pregnancy, and transfusion. HSP candidates waited far longer than non-sensitized peers (median 7.10 vs. 3.81 years; p &amp;lt; 0.001). Across 67 retrospective match runs, the automated KAS identified 13 potentially compatible HSP events compared with 4 under the manual workflow, more than threefold higher (rate ratio 3.25; 95% CI 1.06\u20139.97; p = 0.039). Automated runs completed in 17 \u00b1 0.3 minutes, compared with 152 \u00b1 1.6 minutes for manual workups (p&amp;lt;0.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A locally developed automated KAS substantially improved compatible donor identification for highly sensitized kidney transplant candidates while reducing VXM turnaround from hours to minutes. By enabling comprehensive evaluation of every eligible candidate during each deceased donor workup, automated allocation represents a practical and potentially scalable strategy that could improve equity and operational efficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1922544","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:20Z","timestamp":1787804840000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and clinical implementation of a local automated kidney allocation platform integrating virtual crossmatch"],"prefix":"10.3389","volume":"17","author":[{"given":"Mohammad","family":"Awaji","sequence":"first","affiliation":[{"name":"Histocompatibility and Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]},{"name":"Multiorgan Transplant Center of Excellence, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"AlZahrani","sequence":"additional","affiliation":[{"name":"Histocompatibility and Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafah","family":"Bamrdouf","sequence":"additional","affiliation":[{"name":"Histocompatibility and Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal","family":"AlAbduladheem","sequence":"additional","affiliation":[{"name":"Histocompatibility and Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Histocompatibility and Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Histocompatibility and Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaima","family":"Alkebasi","sequence":"additional","affiliation":[{"name":"Histocompatibility and Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashaer Mohammad","family":"Alshallali","sequence":"additional","affiliation":[{"name":"Digital Health, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Saad","family":"Alreaan","sequence":"additional","affiliation":[{"name":"Digital Health, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Mohammed","family":"Bosbait","sequence":"additional","affiliation":[{"name":"Digital Health, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumayah","family":"Askandarani","sequence":"additional","affiliation":[{"name":"Multiorgan Transplant Center of Excellence, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib Ashoor","family":"Musaied","sequence":"additional","affiliation":[{"name":"Multiorgan Transplant Center of Excellence, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Beleed","family":"Akkari","sequence":"additional","affiliation":[{"name":"Multiorgan Transplant Center of Excellence, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"AlQahtani","sequence":"additional","affiliation":[{"name":"Multiorgan Transplant Center of Excellence, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulnaser Mohammed","family":"Alabadi","sequence":"additional","affiliation":[{"name":"Multiorgan Transplant Center of Excellence, King Fahad Specialist Hospital-Dammam","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA): The new measure of sensitization for transplant candidates","volume":"10","author":"Cecka","year":"2010","journal-title":"Am J Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1498335","article-title":"Transplantation in highly sensitized patients: Challenges and recommendations","volume":"14","author":"Heidt","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.05930615","article-title":"Approach to the highly sensitized kidney transplant candidate","volume":"11","author":"Keith","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13751","article-title":"Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization","volume":"33","author":"Schinstock","year":"2019","journal-title":"Clin Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13759","article-title":"The need for novel trial designs, master protocols, and research consortia in transplantation","volume":"34","author":"Stegall","year":"2019","journal-title":"Clin Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13770","article-title":"Changes in deceased donor kidney transplantation one year after KAS implementation","volume":"16","author":"Stewart","year":"2016","journal-title":"Am J Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ajt.14124","article-title":"OPTN\/SRTR 2015 annual data report: Kidney","volume":"17","author":"Hart","year":"2017","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2015.08.006","article-title":"The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients","volume":"33","author":"Heidt","year":"2015","journal-title":"Transpl Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12475","DOI":"10.3389\/ti.2024.12475","article-title":"European consensus on the management of sensitized kidney transplant recipients: A Delphi study","volume":"37","author":"Furian","year":"2024","journal-title":"Transpl Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17182","article-title":"Scandiatransplant acceptable mismatch program\u201410 years with an effective strategy for transplanting highly sensitized patients","volume":"22","author":"Weinreich","year":"2022","journal-title":"Am J Transplant"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.52843\/cassyni.x2p3mw","article-title":"NHS blood transplant risk communication tools","author":"Ibrahim","year":"2022"},{"key":"B13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/15269248241268697","article-title":"Highly sensitized kidney transplant outcomes after the 2014 kidney allocation system change","volume":"34","author":"Chang","year":"2024","journal-title":"Prog Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2015010023","article-title":"New solutions to reduce discard of kidneys donated for transplantation","volume":"27","author":"Reese","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/tan.13693","article-title":"Out with the old, in with the new: Virtual versus physical crossmatching in the modern era","volume":"94","author":"Morris","year":"2019","journal-title":"HLA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0b013e318191404c","article-title":"A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation","volume":"86","author":"Bingaman","year":"2008","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: Comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000001817","article-title":"HLA diagnostics: Evaluating DSA strength by titration","volume":"102","author":"Tambur","year":"2018","journal-title":"Transplantation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.07720715","article-title":"Allocating deceased donor kidneys to candidates with high panel\u2013reactive antibodies","volume":"11","author":"Gebel","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2020.0304","article-title":"Characteristics and sensitization risk factors in kidney transplant wait list candidates: Panel reactive antibodies status is crucial for successful kidney allocation systems in Turkey","volume":"21","author":"Sahin","year":"2023","journal-title":"Exp Clin Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15149","article-title":"The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS","volume":"19","author":"Jackson","year":"2019","journal-title":"Am J Transplant"},{"key":"B22","article-title":"Sensitization","volume":"2","author":"Cecka","year":"1988","journal-title":"Clin Transpl"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101680","article-title":"Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases","volume":"75","author":"Pandey","year":"2022","journal-title":"Transpl Immunol"},{"key":"B24","unstructured":"Annual Report 2024\n          \n          2024"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000002925","article-title":"Using the virtual crossmatch to allow for safer and more efficient kidney transplantation of highly sensitized patients","volume":"104","author":"Jaramillo","year":"2020","journal-title":"Transplantation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200003150-00008","article-title":"Selective omission of the donor cross-match before renal transplantation: Efficacy, safety and effects on cold storage time","volume":"26","author":"Taylor","year":"2000","journal-title":"Transplantation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2016.11.003","article-title":"Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients","volume":"78","author":"Jani","year":"2017","journal-title":"Hum Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2020.101349","article-title":"The challenge of using the virtual crossmatch as a singular tool for the detection of Anti-HLA antibodies- A study from a tertiary care institute from South India","volume":"65","author":"Kumar","year":"2021","journal-title":"Transpl Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207434","article-title":"Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients","volume":"13","author":"Lee","year":"2018","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02010","article-title":"HLA-epitope matching or eplet risk stratification: The devil is in the details","volume":"9","author":"Tambur","year":"2018","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s0198-8859(02)00382-8","article-title":"HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm","volume":"63","author":"Duquesnoy","year":"2002","journal-title":"Hum Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1016\/j.bbmt.2016.12.341","article-title":"Analysis of predicted indirectly recognizable HLA epitopes (PIRCHE) in mismatched unrelated donor hematopoietic stem cell transplants (HCT): A Center for International Blood and Marrow Transplant Research (CIBMTR) cohort study","volume":"23","author":"Spierings","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1922544\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:21Z","timestamp":1787804841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1922544\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2026.1922544"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1922544","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1922544"}}